FDA Inspection 1169722 — Dendreon Pharmaceuticals LLC
The FDA completed an inspection of Dendreon Pharmaceuticals LLC on April 21, 2022 in Union City, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 21, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Union City, GA (United States)